Key in-hospital and discharge anticoagulants
| Anticoagulant . | n (%) . | |||
|---|---|---|---|---|
| In hospital . | Discharge . | |||
| Prophylactic . | Treatment . | Prophylactic . | Treatment . | |
| Enoxaparin | 2630 (53.6) | 272 (5.5) | 62 (1.3) | 13 (0.3) |
| UFH (subcutaneous) | 984 (20.1) | — | 3 (0.06) | — |
| UFH (IV) | — | 230 (4.7) | — | — |
| Fondaparinux | 1 (0.02) | 5 (0.1) | — | — |
| Apixaban | 309 (6.3) | 52 (1.1) | 180 (3.7) | — |
| Dabigatran | — | — | — | — |
| Rivaroxaban | 112 (2.3) | 51 (1.0) | 336 (6.9) | 1 (0.02) |
| Argatroban (IV) | — | — | — | — |
| Warfarin | — | 77 (1.6) | — | 17 (0.4) |
| Anticoagulant . | n (%) . | |||
|---|---|---|---|---|
| In hospital . | Discharge . | |||
| Prophylactic . | Treatment . | Prophylactic . | Treatment . | |
| Enoxaparin | 2630 (53.6) | 272 (5.5) | 62 (1.3) | 13 (0.3) |
| UFH (subcutaneous) | 984 (20.1) | — | 3 (0.06) | — |
| UFH (IV) | — | 230 (4.7) | — | — |
| Fondaparinux | 1 (0.02) | 5 (0.1) | — | — |
| Apixaban | 309 (6.3) | 52 (1.1) | 180 (3.7) | — |
| Dabigatran | — | — | — | — |
| Rivaroxaban | 112 (2.3) | 51 (1.0) | 336 (6.9) | 1 (0.02) |
| Argatroban (IV) | — | — | — | — |
| Warfarin | — | 77 (1.6) | — | 17 (0.4) |
UFH, unfractionated heparin.